This GRC on Atherosclerosis has been meeting for over 45 years! Over the past four decades, we have learned that atherosclerosis is a complex disease consisting of inflammatory, autoimmune, lipid, and vascular biology components. In this 2019 GRC, we want to take a fresh new look at each of these disease components. We plan to discuss and question the current dogmas about atherosclerotic disease progression, learn about new molecules and new cellular pathways that mechanistically play a role in atherosclerosis development, discuss how to utilize new high dimensional methods to study cellular and molecular components of the atherosclerotic plaque, and identify and discuss new clinical targets – all with the goals to treat, and ultimately prevent, atherosclerosis. Sessions on vascular biology, dyslipidemia, innate and adaptive immunity, noncoding RNAs, and novel therapies have been planned. Please join us in Sunday River, Maine in June 2019 to learn more on molecular and cellular insights and therapeutic approaches in atherosclerosis!
The conference will consist of nine sessions, on the topics listed below. The conference chair is currently developing their preliminary program, which will include the names of the invited speakers and discussion leaders for each of these sessions. The preliminary program will be available by October 15, 2018. Please check back for updates.
- Keynote Session: Diabetes and Dyslipidemia in Atherosclerosis
- Atlas of the Vascular and Immune Cell Repertoire in Health and Disease
- Non-Coding RNAs in Cardiovascular Disease
- Macrophage Death and Resolution of Inflammation in Atherosclerosis
- The Interface of Immune and Metabolic Responses in Atherosclerosis
- Smooth Muscle Cell Reprogramming and Clonality in Vascular Disease
- Endothelial Mechanotransduction, Metabolism and Lipoprotein Transport in Atherosclerosis
- Innate and Adaptive Immunity in Atherosclerosis
- Novel Therapeutic Approaches and Diagnostic Tools for Atherosclerosis